APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galantamine Hydrobromide Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Galantamine Hydrobromide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025182 pages

Choose your research edition.

Industry ResearchGalantamine Hydrobromide Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Galantamine Hydrobromide Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Galantamine Hydrobromide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galantamine Hydrobromide Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Galantamine Hydrobromide Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Galantamine Hydrobromide Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Galantamine Hydrobromide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galantamine Hydrobromide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galantamine Hydrobromide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Galantamine Hydrobromide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Galantamine Hydrobromide Injection include Hikma Pharmaceuticals plc, Mylan Pharmaceuticals ULC, Shire Pharmaceuticals, Hubei Meilin Pharmaceutical Co., Ltd., Hubei Weishi Biopharmaceutical Co., Ltd., Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., Shanghai Xudong Haipu Pharmaceutical Co., Ltd. and Sucheng Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Galantamine Hydrobromide Injection output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Galantamine Hydrobromide Injection by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Galantamine Hydrobromide Injection market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galantamine Hydrobromide Injection and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galantamine Hydrobromide Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galantamine Hydrobromide Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Galantamine Hydrobromide Injection Segment by Company

Hikma Pharmaceuticals plc

Mylan Pharmaceuticals ULC

Shire Pharmaceuticals

Hubei Meilin Pharmaceutical Co., Ltd.

Hubei Weishi Biopharmaceutical Co., Ltd.

Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Sucheng Pharmaceutical Co., Ltd.

Galantamine Hydrobromide Injection Segment by Type

1ml:1mg

1ml:2.5mg

1ml:5mg

Galantamine Hydrobromide Injection Segment by Application

Clinic

Hospital

Other

Galantamine Hydrobromide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galantamine Hydrobromide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galantamine Hydrobromide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galantamine Hydrobromide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galantamine Hydrobromide Injection market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Galantamine Hydrobromide Injection industry.

Chapter 3: Detailed analysis of Galantamine Hydrobromide Injection market competition landscape. Including Galantamine Hydrobromide Injection manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Galantamine Hydrobromide Injection by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Galantamine Hydrobromide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Galantamine Hydrobromide Injection Industry Trends Table 2. Galantamine Hydrobromide Injection Industry Drivers Table 3. Galantamine Hydrobromide Injection Industry Opportunities and Challenges Table 4. Galantamine Hydrobromide Injection Industry Restraints Table 5. Global Galantamine Hydrobromide Injection Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Galantamine Hydrobromide Injection Production Value Share by Manufacturers (2021-2026) Table 7. Global Galantamine Hydrobromide Injection Production by Manufacturers (Units) & (2021-2026) Table 8. Global Galantamine Hydrobromide Injection Production Market Share by Manufacturers Table 9. Global Galantamine Hydrobromide Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Galantamine Hydrobromide Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Galantamine Hydrobromide Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Galantamine Hydrobromide Injection Manufacturers, Product Type & Application Table 13. Global Galantamine Hydrobromide Injection Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Galantamine Hydrobromide Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of 1ml:1mg Table 17. Major Manufacturers of 1ml:2.5mg Table 18. Major Manufacturers of 1ml:5mg Table 19. Global Galantamine Hydrobromide Injection Production by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Galantamine Hydrobromide Injection Production by Type (2021-2026) & (Units) Table 21. Global Galantamine Hydrobromide Injection Production by Type (2027-2032) & (Units) Table 22. Global Galantamine Hydrobromide Injection Production Market Share by Type (2021-2026) Table 23. Global Galantamine Hydrobromide Injection Production Market Share by Type (2027-2032) Table 24. Global Galantamine Hydrobromide Injection Production Value by Type 2021 VS 2025 VS 2032 (Units) Table 25. Global Galantamine Hydrobromide Injection Production Value by Type (2021-2026) & (Units) Table 26. Global Galantamine Hydrobromide Injection Production Value by Type (2027-2032) & (Units) Table 27. Global Galantamine Hydrobromide Injection Production Value Market Share by Type (2021-2026) Table 28. Global Galantamine Hydrobromide Injection Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Other Table 32. Global Galantamine Hydrobromide Injection Production by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Galantamine Hydrobromide Injection Production by Application (2021-2026) & (Units) Table 34. Global Galantamine Hydrobromide Injection Production by Application (2027-2032) & (Units) Table 35. Global Galantamine Hydrobromide Injection Production Market Share by Application (2021-2026) Table 36. Global Galantamine Hydrobromide Injection Production Market Share by Application (2027-2032) Table 37. Global Galantamine Hydrobromide Injection Production Value by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Galantamine Hydrobromide Injection Production Value by Application (2021-2026) & (Units) Table 39. Global Galantamine Hydrobromide Injection Production Value by Application (2027-2032) & (Units) Table 40. Global Galantamine Hydrobromide Injection Production Value Market Share by Application (2021-2026) Table 41. Global Galantamine Hydrobromide Injection Production Value Market Share by Application (2027-2032) Table 42. Hikma Pharmaceuticals plc Company Information Table 43. Hikma Pharmaceuticals plc Business Overview Table 44. Hikma Pharmaceuticals plc Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Hikma Pharmaceuticals plc Galantamine Hydrobromide Injection Product Portfolio Table 46. Hikma Pharmaceuticals plc Recent Development Table 47. Mylan Pharmaceuticals ULC Company Information Table 48. Mylan Pharmaceuticals ULC Business Overview Table 49. Mylan Pharmaceuticals ULC Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Mylan Pharmaceuticals ULC Galantamine Hydrobromide Injection Product Portfolio Table 51. Mylan Pharmaceuticals ULC Recent Development Table 52. Shire Pharmaceuticals Company Information Table 53. Shire Pharmaceuticals Business Overview Table 54. Shire Pharmaceuticals Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 55. Shire Pharmaceuticals Galantamine Hydrobromide Injection Product Portfolio Table 56. Shire Pharmaceuticals Recent Development Table 57. Hubei Meilin Pharmaceutical Co., Ltd. Company Information Table 58. Hubei Meilin Pharmaceutical Co., Ltd. Business Overview Table 59. Hubei Meilin Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Hubei Meilin Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio Table 61. Hubei Meilin Pharmaceutical Co., Ltd. Recent Development Table 62. Hubei Weishi Biopharmaceutical Co., Ltd. Company Information Table 63. Hubei Weishi Biopharmaceutical Co., Ltd. Business Overview Table 64. Hubei Weishi Biopharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Hubei Weishi Biopharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio Table 66. Hubei Weishi Biopharmaceutical Co., Ltd. Recent Development Table 67. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Company Information Table 68. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Business Overview Table 69. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio Table 71. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Recent Development Table 72. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information Table 73. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Business Overview Table 74. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio Table 76. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Development Table 77. Sucheng Pharmaceutical Co., Ltd. Company Information Table 78. Sucheng Pharmaceutical Co., Ltd. Business Overview Table 79. Sucheng Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sucheng Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio Table 81. Sucheng Pharmaceutical Co., Ltd. Recent Development Table 82. Global Galantamine Hydrobromide Injection Production by Region: 2021 VS 2025 VS 2032 (Units) Table 83. Global Galantamine Hydrobromide Injection Production by Region (2021-2026) & (Units) Table 84. Global Galantamine Hydrobromide Injection Production Market Share by Region (2021-2026) Table 85. Global Galantamine Hydrobromide Injection Production Forecast by Region (2027-2032) & (Units) Table 86. Global Galantamine Hydrobromide Injection Production Market Share Forecast by Region (2027-2032) Table 87. Global Galantamine Hydrobromide Injection Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Global Galantamine Hydrobromide Injection Production Value by Region (2021-2026) & (US$ Million) Table 89. Global Galantamine Hydrobromide Injection Production Value Share by Region (2021-2026) Table 90. Global Galantamine Hydrobromide Injection Production Value by Region (2027-2032) & (US$ Million) Table 91. Global Galantamine Hydrobromide Injection Production Value Share by Region: (2027-2032) & (US$ Million) Table 92. Global Galantamine Hydrobromide Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 93. Global Galantamine Hydrobromide Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 94. Global Galantamine Hydrobromide Injection Consumption by Region: 2021 VS 2025 VS 2032 (Units) Table 95. Global Galantamine Hydrobromide Injection Consumption by Region (2021-2026) & (Units) Table 96. Global Galantamine Hydrobromide Injection Consumption Market Share by Region (2021-2026) Table 97. Global Galantamine Hydrobromide Injection Consumption Forecasted by Region (2027-2032) & (Units) Table 98. Global Galantamine Hydrobromide Injection Consumption Forecasted Market Share by Region (2027-2032) Table 99. North America Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 100. North America Galantamine Hydrobromide Injection Consumption by Country (2021-2026) & (Units) Table 101. North America Galantamine Hydrobromide Injection Consumption by Country (2027-2032) & (Units) Table 102. Europe Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 103. Europe Galantamine Hydrobromide Injection Consumption by Country (2021-2026) & (Units) Table 104. Europe Galantamine Hydrobromide Injection Consumption by Country (2027-2032) & (Units) Table 105. Asia Pacific Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 106. Asia Pacific Galantamine Hydrobromide Injection Consumption by Country (2021-2026) & (Units) Table 107. Asia Pacific Galantamine Hydrobromide Injection Consumption by Country (2027-2032) & (Units) Table 108. South America Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 109. South America Galantamine Hydrobromide Injection Consumption by Country (2021-2026) & (Units) Table 110. South America Galantamine Hydrobromide Injection Consumption by Country (2027-2032) & (Units) Table 111. Middle East & Africa Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 112. Middle East & Africa Galantamine Hydrobromide Injection Consumption by Country (2021-2026) & (Units) Table 113. Middle East & Africa Galantamine Hydrobromide Injection Consumption by Country (2027-2032) & (Units) Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Galantamine Hydrobromide Injection Distributors List Table 117. Galantamine Hydrobromide Injection Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Galantamine Hydrobromide Injection Product Image Figure 2. Global Galantamine Hydrobromide Injection Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 4. Global Galantamine Hydrobromide Injection Production Capacity (2021-2032) & (Units) Figure 5. Global Galantamine Hydrobromide Injection Production (2021-2032) & (Units) Figure 6. Global Galantamine Hydrobromide Injection Average Price (US$/Unit) & (2021-2032) Figure 7. Global Top 5 and 10 Galantamine Hydrobromide Injection Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1ml:1mg Image Figure 10. 1ml:2.5mg Image Figure 11. 1ml:5mg Image Figure 12. Global Galantamine Hydrobromide Injection Production by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Galantamine Hydrobromide Injection Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Galantamine Hydrobromide Injection Production Market Share by Type (2021-2032) Figure 15. Global Galantamine Hydrobromide Injection Production Value by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Galantamine Hydrobromide Injection Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Galantamine Hydrobromide Injection Production Value Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Other Image Figure 21. Global Galantamine Hydrobromide Injection Production by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Galantamine Hydrobromide Injection Production Market Share 2021 VS 2025 VS 2032 Figure 23. Global Galantamine Hydrobromide Injection Production Market Share by Application (2021-2032) Figure 24. Global Galantamine Hydrobromide Injection Production Value by Application (2021 VS 2025 VS 2032) & (Units) Figure 25. Global Galantamine Hydrobromide Injection Production Value Share 2021 VS 2025 VS 2032 Figure 26. Global Galantamine Hydrobromide Injection Production Value Share by Application (2021-2032) Figure 27. Global Galantamine Hydrobromide Injection Production by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Galantamine Hydrobromide Injection Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Galantamine Hydrobromide Injection Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Galantamine Hydrobromide Injection Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 32. Europe Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 34. South America Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Galantamine Hydrobromide Injection Production Value (2021-2032) & (US$ Million) Figure 36. North America Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 37. North America Galantamine Hydrobromide Injection Consumption Market Share by Country (2021-2032) Figure 38. U.S. Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 39. Canada Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 40. Mexico Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 41. Europe Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 42. Europe Galantamine Hydrobromide Injection Consumption Market Share by Country (2021-2032) Figure 43. Germany Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 44. France Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 45. U.K. Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 46. Italy Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 47. Netherlands Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 48. Asia Pacific Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 49. Asia Pacific Galantamine Hydrobromide Injection Consumption Market Share by Country (2021-2032) Figure 50. China Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 51. Japan Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 52. South Korea Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 53. Southeast Asia Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 54. India Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 55. Australia Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 56. South America Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 57. South America Galantamine Hydrobromide Injection Consumption Market Share by Country (2021-2032) Figure 58. Brazil Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 59. Argentina Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 60. Chile Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 61. Colombia Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 62. Middle East & Africa Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 63. Middle East & Africa Galantamine Hydrobromide Injection Consumption Market Share by Country (2021-2032) Figure 64. Egypt Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 65. South Africa Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 66. Israel Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 67. Türkiye Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 68. GCC Countries Galantamine Hydrobromide Injection Consumption and Growth Rate (2021-2032) & (Units) Figure 69. Galantamine Hydrobromide Injection Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Galantamine Hydrobromide Injection Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 1ml:1mg
  • 1ml:2.5mg
  • 1ml:5mg
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Hikma Pharmaceuticals plc
  • Mylan Pharmaceuticals ULC
  • Shire Pharmaceuticals
  • Hubei Meilin Pharmaceutical Co., Ltd.
  • Hubei Weishi Biopharmaceutical Co., Ltd.
  • Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
  • Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
  • Sucheng Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galantamine Hydrobromide Injection Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Galantamine Hydrobromide Injection Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Galantamine Hydrobromide Injection Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Galantamine Hydrobromide Injection Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Galantamine Hydrobromide Injection Market Dynamics
  1. 2.1 Galantamine Hydrobromide Injection Industry Trends
  2. 2.2 Galantamine Hydrobromide Injection Industry Drivers
  3. 2.3 Galantamine Hydrobromide Injection Industry Opportunities and Challenges
  4. 2.4 Galantamine Hydrobromide Injection Industry Restraints
3 Galantamine Hydrobromide Injection Market by Manufacturers
  1. 3.1 Global Galantamine Hydrobromide Injection Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Galantamine Hydrobromide Injection Production by Manufacturers (2021-2026)
  3. 3.3 Global Galantamine Hydrobromide Injection Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Galantamine Hydrobromide Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Galantamine Hydrobromide Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Galantamine Hydrobromide Injection Manufacturers, Product Type & Application
  7. 3.7 Global Galantamine Hydrobromide Injection Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Galantamine Hydrobromide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Galantamine Hydrobromide Injection Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Galantamine Hydrobromide Injection Tier 1, Tier 2, and Tier 3
4 Galantamine Hydrobromide Injection Market by Type
  1. 4.1 Galantamine Hydrobromide Injection Type Introduction
  2. 4.1.1 1ml:1mg
  3. 4.1.2 1ml:2.5mg
  4. 4.1.3 1ml:5mg
  5. 4.2 Global Galantamine Hydrobromide Injection Production by Type
  6. 4.2.1 Global Galantamine Hydrobromide Injection Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Galantamine Hydrobromide Injection Production by Type (2021-2032)
  8. 4.2.3 Global Galantamine Hydrobromide Injection Production Market Share by Type (2021-2032)
  9. 4.3 Global Galantamine Hydrobromide Injection Production Value by Type
  10. 4.3.1 Global Galantamine Hydrobromide Injection Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Galantamine Hydrobromide Injection Production Value by Type (2021-2032)
  12. 4.3.3 Global Galantamine Hydrobromide Injection Production Value Market Share by Type (2021-2032)
5 Galantamine Hydrobromide Injection Market by Application
  1. 5.1 Galantamine Hydrobromide Injection Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Galantamine Hydrobromide Injection Production by Application
  6. 5.2.1 Global Galantamine Hydrobromide Injection Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galantamine Hydrobromide Injection Production by Application (2021-2032)
  8. 5.2.3 Global Galantamine Hydrobromide Injection Production Market Share by Application (2021-2032)
  9. 5.3 Global Galantamine Hydrobromide Injection Production Value by Application
  10. 5.3.1 Global Galantamine Hydrobromide Injection Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Galantamine Hydrobromide Injection Production Value by Application (2021-2032)
  12. 5.3.3 Global Galantamine Hydrobromide Injection Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hikma Pharmaceuticals plc
  2. 6.1.1 Hikma Pharmaceuticals plc Company Information
  3. 6.1.2 Hikma Pharmaceuticals plc Business Overview
  4. 6.1.3 Hikma Pharmaceuticals plc Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Hikma Pharmaceuticals plc Galantamine Hydrobromide Injection Product Portfolio
  6. 6.1.5 Hikma Pharmaceuticals plc Recent Developments
  7. 6.2 Mylan Pharmaceuticals ULC
  8. 6.2.1 Mylan Pharmaceuticals ULC Company Information
  9. 6.2.2 Mylan Pharmaceuticals ULC Business Overview
  10. 6.2.3 Mylan Pharmaceuticals ULC Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Pharmaceuticals ULC Galantamine Hydrobromide Injection Product Portfolio
  12. 6.2.5 Mylan Pharmaceuticals ULC Recent Developments
  13. 6.3 Shire Pharmaceuticals
  14. 6.3.1 Shire Pharmaceuticals Company Information
  15. 6.3.2 Shire Pharmaceuticals Business Overview
  16. 6.3.3 Shire Pharmaceuticals Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Shire Pharmaceuticals Galantamine Hydrobromide Injection Product Portfolio
  18. 6.3.5 Shire Pharmaceuticals Recent Developments
  19. 6.4 Hubei Meilin Pharmaceutical Co., Ltd.
  20. 6.4.1 Hubei Meilin Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Hubei Meilin Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Hubei Meilin Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Hubei Meilin Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio
  24. 6.4.5 Hubei Meilin Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Hubei Weishi Biopharmaceutical Co., Ltd.
  26. 6.5.1 Hubei Weishi Biopharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Hubei Weishi Biopharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Hubei Weishi Biopharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Hubei Weishi Biopharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio
  30. 6.5.5 Hubei Weishi Biopharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio
  36. 6.6.5 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
  38. 6.7.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio
  42. 6.7.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Sucheng Pharmaceutical Co., Ltd.
  44. 6.8.1 Sucheng Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Sucheng Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Sucheng Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Sucheng Pharmaceutical Co., Ltd. Galantamine Hydrobromide Injection Product Portfolio
  48. 6.8.5 Sucheng Pharmaceutical Co., Ltd. Recent Developments
7 Global Galantamine Hydrobromide Injection Production by Region
  1. 7.1 Global Galantamine Hydrobromide Injection Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Galantamine Hydrobromide Injection Production by Region (2021-2032)
  3. 7.2.1 Global Galantamine Hydrobromide Injection Production by Region (2021-2026)
  4. 7.2.2 Global Galantamine Hydrobromide Injection Production Forecast by Region (2027-2032)
  5. 7.3 Global Galantamine Hydrobromide Injection Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Galantamine Hydrobromide Injection Production Value by Region (2021-2032)
  7. 7.4.1 Global Galantamine Hydrobromide Injection Production Value by Region (2021-2026)
  8. 7.4.2 Global Galantamine Hydrobromide Injection Production Value by Region (2027-2032)
  9. 7.5 Global Galantamine Hydrobromide Injection Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Galantamine Hydrobromide Injection Production Value (2021-2032)
  12. 7.6.2 Europe Galantamine Hydrobromide Injection Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Galantamine Hydrobromide Injection Production Value (2021-2032)
  14. 7.6.4 South America Galantamine Hydrobromide Injection Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Galantamine Hydrobromide Injection Production Value (2021-2032)
8 Global Galantamine Hydrobromide Injection Consumption by Region
  1. 8.1 Global Galantamine Hydrobromide Injection Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Galantamine Hydrobromide Injection Consumption by Region (2021-2032)
  3. 8.2.1 Global Galantamine Hydrobromide Injection Consumption by Region (2021-2026)
  4. 8.2.2 Global Galantamine Hydrobromide Injection Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Galantamine Hydrobromide Injection Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Galantamine Hydrobromide Injection Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Galantamine Hydrobromide Injection Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Galantamine Hydrobromide Injection Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Galantamine Hydrobromide Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Galantamine Hydrobromide Injection Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galantamine Hydrobromide Injection Value Chain Analysis
  2. 9.1.1 Galantamine Hydrobromide Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galantamine Hydrobromide Injection Production Mode & Process
  6. 9.2 Galantamine Hydrobromide Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galantamine Hydrobromide Injection Distributors
  9. 9.2.3 Galantamine Hydrobromide Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst